Moderna closed at $200.10, a decrease of 1.25%.
Large options trades in Moderna revealed a near-perfect standoff between bullish and bearish positioning, with two dominant call spreads centered on the $210.00–$222.50 strike zone. One institutional player paid a substantial net debit to open a bull call spread, while an almost equally sized bear call spread collected a net credit. This offsetting structure suggests that despite the underlying stock pulling back, professional traders remain divided but lean toward capping upside rather than chasing a breakout.
>>>Start OPTIONS trading & earn up to SGD 200 in rewards!
Options Indicators
Moderna currently has an implied volatility of 92.90%, and with an IV percentile of 82.80%, its volatility backdrop is clearly elevated, indicating that options are priced expensively relative to their own historical range. At the same time, the IV/HV ratio of 0.84 suggests implied volatility is running below realized volatility, which can matter when judging whether current premiums fully reflect the stock’s actual movement profile, but on a percentile basis options still sit in a rich pricing zone.
The Call/Put volume ratio is 0.85.
Large Trades
A bull call spread with a $544,600 net debit was one of the standout large trades, built by buying 1,650 Oct. 30, 2026 $210.00 calls and selling 1,650 Oct. 30, 2026 $222.50 calls. With Moderna referenced at $200.10, both strikes were out of the money, making this a defined-risk bullish directional bet that targets upside into the $210.00 to $222.50 zone while capping gains above the short strike. The net debit shows the trader was willing to pay premium for upside exposure rather than collect income, which typically reflects constructive expectations but with disciplined risk control through the call sale.
A bear call spread with a $536,300 net credit was the other key large trade, established by selling 1,625 Oct. 30, 2026 $210.00 calls and buying 1,625 Oct. 30, 2026 $222.50 calls. Since Moderna was at $200.10, both call strikes were also out of the money, and this structure expresses a moderately bearish to neutral view that the stock will remain below $210.00 into expiration. The net credit indicates a premium-collection strategy, with the long $222.50 call serving as risk protection; strategically, this points to expectations for upside containment rather than a sharp rally.
Overall, the large-trade flow leans slightly bearish. Although there was a meaningful bullish upside spread placed above the market, the presence of an almost equally sized bear call spread, together with the additional call-selling activity in the full tape, suggests institutions were more inclined to fade or cap upside than to chase a breakout. Taken together, the bulk-order positioning implies cautious sentiment on Moderna, with market participants appearing to expect limited upside and a higher probability that the stock stays below key out-of-the-money call strikes rather than making a sustained move higher.
Strategy Reference
For traders seeking a low assignment probability on the sell side, shorting a single out-of-the-money call at the $222.50 strike for the Oct. 30, 2026 expiration may offer a reasonable premium cushion, whereas a defined-risk bear call spread using the $210.00/$222.50 strikes provides a margin-efficient alternative without unlimited tail exposure.
Comments